Trial Profile
Efficacy and tolerability of posology adaptation of irbesartan in ambulatory hypertensive patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2009
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms APROVE
- Sponsors Sanofi
- 12 Sep 2006 New trial record.